BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29725763)

  • 1. Tumor cell expression of CD163 is associated to postoperative radiotherapy and poor prognosis in patients with breast cancer treated with breast-conserving surgery.
    Garvin S; Oda H; Arnesson LG; Lindström A; Shabo I
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1253-1263. PubMed ID: 29725763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival.
    Shabo I; Stål O; Olsson H; Doré S; Svanvik J
    Int J Cancer; 2008 Aug; 123(4):780-6. PubMed ID: 18506688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage traits in cancer cells are induced by macrophage-cancer cell fusion and cannot be explained by cellular interaction.
    Shabo I; Midtbö K; Andersson H; Åkerlund E; Olsson H; Wegman P; Gunnarsson C; Lindström A
    BMC Cancer; 2015 Nov; 15():922. PubMed ID: 26585897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in intra-tumoral macrophage infiltration and radiotherapy response among intrinsic subtypes in pT1-T2 breast cancers treated with breast-conserving surgery.
    Garvin S; Vikhe Patil E; Arnesson LG; Oda H; Hedayati E; Lindström A; Shabo I
    Virchows Arch; 2019 Aug; 475(2):151-162. PubMed ID: 30915533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M2-macrophage infiltration and macrophage traits of tumor cells in urinary bladder cancer.
    Aljabery F; Olsson H; Gimm O; Jahnson S; Shabo I
    Urol Oncol; 2018 Apr; 36(4):159.e19-159.e26. PubMed ID: 29288002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
    Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
    Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time.
    Shabo I; Olsson H; Sun XF; Svanvik J
    Int J Cancer; 2009 Oct; 125(8):1826-31. PubMed ID: 19582880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer.
    Fortis SP; Sofopoulos M; Sotiriadou NN; Haritos C; Vaxevanis CK; Anastasopoulou EA; Janssen N; Arnogiannaki N; Ardavanis A; Pawelec G; Perez SA; Baxevanis CN
    J Immunother Cancer; 2017; 5():39. PubMed ID: 28428887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated macrophages are strongly related to vascular invasion, non-luminal subtypes, and interval breast cancer.
    Klingen TA; Chen Y; Aas H; Wik E; Akslen LA
    Hum Pathol; 2017 Nov; 69():72-80. PubMed ID: 28923419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated macrophages and crown-like structures in adipose tissue in breast cancer.
    Cha YJ; Kim ES; Koo JS
    Breast Cancer Res Treat; 2018 Jul; 170(1):15-25. PubMed ID: 29468486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association.
    Kridel R; Xerri L; Gelas-Dore B; Tan K; Feugier P; Vawda A; Canioni D; Farinha P; Boussetta S; Moccia AA; Brice P; Chavez EA; Kyle AH; Scott DW; Sanders AD; Fabiani B; Slack GW; Minchinton AI; Haioun C; Connors JM; Sehn LH; Steidl C; Gascoyne RD; Salles G
    Clin Cancer Res; 2015 Aug; 21(15):3428-35. PubMed ID: 25869385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
    Medrek C; Pontén F; Jirström K; Leandersson K
    BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Impact of CD163+ Macrophages in Tumor Stroma and CD8+ T-Cells in Cancer Cell Nests in Invasive Extrahepatic Bile Duct Cancer.
    Miura T; Yoshizawa T; Hirai H; Seino H; Morohashi S; Wu Y; Wakiya T; Kimura N; Kudo D; Ishido K; Toyoki Y; Kijima H; Hakamada K
    Anticancer Res; 2017 Jan; 37(1):183-190. PubMed ID: 28011489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor associated macrophage × cancer cell hybrids may acquire cancer stem cell properties in breast cancer.
    Ding J; Jin W; Chen C; Shao Z; Wu J
    PLoS One; 2012; 7(7):e41942. PubMed ID: 22848668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype.
    Komohara Y; Hirahara J; Horikawa T; Kawamura K; Kiyota E; Sakashita N; Araki N; Takeya M
    J Histochem Cytochem; 2006 Jul; 54(7):763-71. PubMed ID: 16517975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer expression of DAP12 is associated with skeletal and liver metastases and poor survival.
    Shabo I; Olsson H; Stål O; Svanvik J
    Clin Breast Cancer; 2013 Oct; 13(5):371-7. PubMed ID: 23810293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells.
    Maniecki MB; Etzerodt A; Ulhøi BP; Steiniche T; Borre M; Dyrskjøt L; Orntoft TF; Moestrup SK; Møller HJ
    Int J Cancer; 2012 Nov; 131(10):2320-31. PubMed ID: 22362417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse.
    Reinartz S; Schumann T; Finkernagel F; Wortmann A; Jansen JM; Meissner W; Krause M; Schwörer AM; Wagner U; Müller-Brüsselbach S; Müller R
    Int J Cancer; 2014 Jan; 134(1):32-42. PubMed ID: 23784932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer.
    Edin S; Wikberg ML; Dahlin AM; Rutegård J; Öberg Å; Oldenborg PA; Palmqvist R
    PLoS One; 2012; 7(10):e47045. PubMed ID: 23077543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.